Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionWest Branch Capital LLC
Latest Disclosed Ownership2,750 shares
Latest Disclosed Value $ 166,788
West Branch Capital LLC reports 3.44% decrease in ownership of BRM / Bristol-Myers Squibb Company

On April 14, 2026 - West Branch Capital LLC filed a 13F-HR form disclosing ownership of 2,750 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $144,155 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 16, 2026 disclosing 2,848 shares of Bristol-Myers Squibb Company. This represents a change in shares of -3.44% during the quarter. The current value of the position is $130,432 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-14 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 2,750 -98 -3.44 167 8.50 0.0447
2026-01-16 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 2,848 85 3.08 154 23.39 0.0396
2025-10-21 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 2,763 400 16.93 125 13.76 0.0327
2025-07-16 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 2,363 -500 -17.46 109 -37.36 0.0323
2025-04-16 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 2,863 0 0.00 175 8.07 0.0582
2025-01-17 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 2,863 0 0.00 162 8.78 0.0516
2024-10-18 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 2,863 13 0.46 148 25.42 0.0512
2024-07-26 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 2,850 600 26.67 118 -3.28 0.0440
2024-04-24 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 2,250 -145 -6.05 122 0.00 0.0492
2024-01-19 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 2,395 -1,519 -38.81 123 -46.26 0.0578
2023-10-20 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 3,914 -82 -2.05 227 -10.98 0.1192
2023-08-07 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 3,996 -355 -8.16 256 -15.28 0.1275
2023-04-20 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 4,351 -192 -4.23 302 -7.67 0.1680
2023-01-27 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 4,543 8 0.18 327 1.24 0.2019
2022-10-19 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 4,535 8 0.18 322 -7.74 0.2001
2022-07-28 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 4,527 316 7.50 349 13.31 0.2018
2022-05-03 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 4,211 -292 -6.48 308 9.61 0.1472
2022-01-24 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 4,503 -68 -1.49 281 4.07 0.1196
2021-11-09 2021-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 4,571 -54 -1.17 270 -12.62 0.1299
2021-08-17 2021-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 4,625 12 0.26 309 6.19 0.1518
2021-05-14 2021-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 4,613 -1,326 -22.33 291 -20.92 0.1703
2021-02-08 2020-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 5,939 -518 -8.02 368 -5.40 0.2175
2020-10-13 2020-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 6,457 -9,841 -60.38 389 -59.39 0.2482
2020-07-08 2020-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 16,298 6,491 66.19 958 75.14 0.6749
2020-04-20 2020-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 9,807 341 3.60 547 -10.03 0.5225
2020-01-07 2019-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 9,466 4,168 78.67 608 126.02 0.4234
2019-10-23 2019-09-30 13F Bristol-Myers Squibb COM 110122108 5,298 -465 -8.07 269 3.07 0.1992
2019-08-05 2019-06-30 13F Bristol-Myers Squibb COM 110122108 5,763 -328 -5.38 261 -10.31 0.2153
2019-04-30 2019-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 6,091 -104 -1.68 291 -9.63 0.2605
2019-02-06 2018-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 6,195 -1,173 -15.92 322 -29.54 0.3392
2018-10-15 2018-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 7,368 -5 -0.07 457 12.01 0.3390
2018-08-02 2018-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 7,373 2,921 65.61 408 44.68 0.3216
2018-05-02 2018-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 4,452 4,452 282 0.3096
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.